Benzodiazepine Use in Early Pregnancy Linked to Spontaneous Abortion
According to the results of a recently published nested case-control study, exposure to any benzodiazepine in early pregnancy may increase the risk of spontaneous abortion (SA).
Mood Disorders
Abnormal Superficial White Matter Connectivity Linked to Schizophrenia, Bipolar Disorder
Generalized fractional anisotropy reductions in bundles connecting regions involved in mood regulation and motor function were seen in patients with schizophrenia and bipolar disorder.
Novel Treatment for Schizophrenia Gets FDA’s Breakthrough Therapy Designation
The Food and Drug Administration (FDA) has granted Breakthrough Therapy designation to SEP-363856 (Sunovion), an investigational treatment for schizophrenia.
Higher Risk for Mental Disorders Seen in Patients With Psoriasis
Time to onset found to be 2 to 3 months for anxiety disorders and other conditions.
Nurse-Led Telephone Intervention Beneficial for Medication Adherence in Schizophrenia
Patients with schizophrenia who participated in a telephone intervention problem-solving program were found to have higher rates of medication adherence compared with patients who received routine hospital care for schizophrenia.
Promoting Smoking Cessation in Individuals With Schizophrenia
Researchers found data to support the benefits of proactively helping patients with schizophrenia quit smoking, including the idea to try to create a substitute that would give patients the benefits that they find by self-medicating with cigarettes, but without the unhealthy adverse effects.
Autism Symptoms, Loneliness Moderated by Capacity for Pleasure
Adults who experienced less pleasure reported high levels of loneliness, and loneliness was the strongest predictor of depressive symptoms.
1998 to 2015 Saw Increase in Outpatient Depression Treatment
Proportion using psychotherapy decreased; proportion receiving drugs remained stable.
Solar Insolation Changes May Increase Risk for Suicide in Bipolar Disorder
Patients with bipolar disorder may be at increased risk for suicide attempts if they live in a location with large changes in solar insolation between winter and summer.
First Prescription Device Approved to Treat ADHD
The FDA has permitted for marketing the first medical device indicated for the treatment of attention deficit hyperactivity disorder ADHD.
Next post in ADHD Information Center
